Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Holmes

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2003
Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genesDaniel R Gentry, Karen A Ingraham, Michael J Stanhope, et al.
Bioorganic & Medicinal Chemistry|November 4, 2011
Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activitySamra Kapić, Hana Cipčić Paljetak, Ivana Palej Jakopović, et al.
Journal of the American College of Cardiology|January 13, 2018
Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS StudyDhanunjaya Lakkireddy, Mohit Turagam, Muhammad Rizwan Afzal, et al.
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Microbiology (Reading, England)|July 6, 2000
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulenceAlison F Chalker, Karen A Ingraham, R Dwayne Lunsford, et al.
American Heart Journal|February 26, 2008
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapiesE Marc Jolicoeur, Christopher B Granger, Timothy D Henry, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In VivoHana Čipčić Paljetak, Donatella Verbanac, Jasna Padovan, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniaeSharon Min, Karen Ingraham, Jianzhong Huang, et al.
Journal of Bacteriology|March 6, 2003
Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniaePan F Chan, Karen M O'Dwyer, Leslie M Palmer, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2014
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylaseSeda Arat, Aaron Spivak, Stephanie Van Horn, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 23, 2003
Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genesDaniel R Gentry, Karen A Ingraham, Michael J Stanhope, et al.
Bioorganic & Medicinal Chemistry|November 4, 2011
Synthesis of macrolones with central piperazine ring in the linker and its influence on antibacterial activitySamra Kapić, Hana Cipčić Paljetak, Ivana Palej Jakopović, et al.
Journal of the American College of Cardiology|January 13, 2018
Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS StudyDhanunjaya Lakkireddy, Mohit Turagam, Muhammad Rizwan Afzal, et al.
Microbiology (Reading, England)|February 7, 2001
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infectionJun Yu, Alexander P Bryant, Andrea Marra, et al.
Microbiology (Reading, England)|July 6, 2000
The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulenceAlison F Chalker, Karen A Ingraham, R Dwayne Lunsford, et al.
American Heart Journal|February 26, 2008
Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapiesE Marc Jolicoeur, Christopher B Granger, Timothy D Henry, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In VivoHana Čipčić Paljetak, Donatella Verbanac, Jasna Padovan, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniaeSharon Min, Karen Ingraham, Jianzhong Huang, et al.
Journal of Bacteriology|March 6, 2003
Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniaePan F Chan, Karen M O'Dwyer, Leslie M Palmer, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2014
Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylaseSeda Arat, Aaron Spivak, Stephanie Van Horn, et al.
Pageof 4